Free Trial

Hyperfine Q2 2024 Earnings Report

Hyperfine logo
$0.72 -0.06 (-7.40%)
As of 03/28/2025 04:00 PM Eastern

Hyperfine EPS Results

Actual EPS
-$0.14
Consensus EPS
-$0.14
Beat/Miss
Met Expectations
One Year Ago EPS
-$0.15

Hyperfine Revenue Results

Actual Revenue
$3.63 million
Expected Revenue
$3.15 million
Beat/Miss
Beat by +$480.00 thousand
YoY Revenue Growth
N/A

Hyperfine Announcement Details

Quarter
Q2 2024
Time
After Market Closes

Conference Call Resources

Remove Ads

Hyperfine Earnings Headlines

Lake Street Capital Begins Coverage on Hyperfine (NASDAQ:HYPR)
Elon’s ‘Strike Squad’ sends these 9 stocks soaring?
Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the federal government. And that's creating a huge buying opportunity for the stocks involved. Put simply, under Elon's watchful eye, the U.S. government is rapidly adopting AI technology. And that's sending certain stocks soaring higher.
Q1 Earnings Forecast for Hyperfine Issued By B. Riley
Hyperfine initiated with a Buy at Lake Street
B. Riley Cuts Hyperfine (NASDAQ:HYPR) Price Target to $1.20
See More Hyperfine Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Hyperfine? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Hyperfine and other key companies, straight to your email.

About Hyperfine

Hyperfine (NASDAQ:HYPR), a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.

View Hyperfine Profile

More Earnings Resources from MarketBeat